Background:
The impact of vitamin D supplementation on cardiovascular outcomes and mortality risk reduction remains unclear due to conflicting study findings.
Methods:
We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs), published between 1983 and 2022, that reported the effect of vitamin D supplementation in adults versus placebo or no treatment on all-cause mortality (ACM), cardiovascular mortality (CVM), non-cardiovascular mortality (non-CVM), and cardiovascular morbidities. Only studies with a follow-up period longer than one year were included. The primary outcomes were ACM and CVM. Secondary outcomes were non-CVM, myocardial infarction, stroke, heart failure, and major or extended adverse cardiovascular events. Subgroup analyses were performed according to low-, fair- and good-quality RCTs.
Results:
Eighty RCTs were assessed, including 82,210 participants receiving vitamin D supplementation and 80,921 receiving placebo or no treatment. The participants' mean (SD) age was 66.1 (11.2) years, and 68.6% were female. Vitamin D supplementation was associated with a lower risk of ACM (OR: 0.95 [95%CI 0.91-0.99] = 0.013), was close to statistical significance for a lower risk of non-CVM (OR: 0.94 [95%CI 0.87-1.00] = 0.055), and was not statistically associated with a lower risk of any cardiovascular morbi-mortality outcome. Meta-analysis of low-quality RCTs showed no association with cardiovascular or non-cardiovascular morbi-mortality outcomes.
Conclusions:
The emerging results of our meta-analysis present evidence that vitamin D supplementation appears to decrease the risk of ACM (especially convincing in the fair- and good-quality RCTs), while not showing a decrease in the specific cardiovascular morbidity and mortality risk. Thus, we conclude that further research is warranted in this area, with well-planned and executed studies as the basis for more robust recommendations.
Citing Articles
Association of Vitamin D Deficiency as an Independent Risk Factor for Myocardial Infarction and Its Therapeutic Implications: A Systematic Review.
Balasubramanian A, Kunchala K, Shahbaz A, Kar A, Sankar J, Anand S
Cureus. 2025; 17(1):e77375.
PMID: 39944452
PMC: 11817865.
DOI: 10.7759/cureus.77375.
Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.
Bischoff-Ferrari H, Gangler S, Wieczorek M, Belsky D, Ryan J, Kressig R
Nat Aging. 2025; .
PMID: 39900648
DOI: 10.1038/s43587-024-00793-y.
Disease Risk Score Derivation and Validation in Abu Dhabi, United Arab Emirates: A Retrospective Cohort Study.
AlKetbi L, Nagelkerke N, AlAlawi N, Humaid A, AlKetbi R, Aleissaee H
J Am Heart Assoc. 2024; 13(23):e035930.
PMID: 39611388
PMC: 11681588.
DOI: 10.1161/JAHA.124.035930.
Is vitamin D associated with disease activity in patients with axial or peripheral spondyloarthritis? A real-life study.
Mbuyi M, Kavangh H, Grubisic F, Doko Vajdic I, Grazio S
Rheumatol Int. 2024; 44(10):2079-2087.
PMID: 39180527
DOI: 10.1007/s00296-024-05674-6.
Insights into the Role of Vitamin D in the Prevention and Control of Cancer and Other Chronic Noncommunicable Diseases: Shedding Further Light on a Captivating Subject.
Martin-Gorgojo A, Martin-Moreno J
Nutrients. 2024; 16(13).
PMID: 38999912
PMC: 11243713.
DOI: 10.3390/nu16132166.
Chronic Kidney Disease Diets for Kidney Failure Prevention: Insights from the IL-11 Paradigm.
Elshoff D, Mehta P, Ziouzenkova O
Nutrients. 2024; 16(9).
PMID: 38732588
PMC: 11085624.
DOI: 10.3390/nu16091342.
Evaluating low and high vitamin D levels in Ecuadorian cities from 2018 to 2022: interrupted time series and a cross-sectional study.
Zurita-Salinas C, Tello B, Duenas-Espin I, Zurita J, Acosta W, Leon C
BMJ Open. 2024; 14(4):e079960.
PMID: 38670624
PMC: 11057257.
DOI: 10.1136/bmjopen-2023-079960.
Higher Vitamin D Levels before Methotrexate Therapy Initiation Are Associated with Lower Subsequent Mortality in Patients with Rheumatoid Arthritis.
Malakooti S, Siddiqui H, Wilson B, Bej T, OMara M, Desotelle A
Nutrients. 2024; 16(3).
PMID: 38337687
PMC: 10857393.
DOI: 10.3390/nu16030401.
Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 µg) of Vitamin D for Adults in the General Population.
Pludowski P, Grant W, Karras S, Zittermann A, Pilz S
Nutrients. 2024; 16(3).
PMID: 38337676
PMC: 10857599.
DOI: 10.3390/nu16030391.
Is Dietary (Food) Supplement Intake Reported in European National Nutrition Surveys?.
Papatesta E, Kanellou A, Peppa E, Trichopoulou A
Nutrients. 2023; 15(24).
PMID: 38140349
PMC: 10871081.
DOI: 10.3390/nu15245090.
Vitamin D Levels Are Associated with Cardiovascular Disease Events but Not with Cardiovascular Disease or Overall Mortality: A Prospective Population-Based Study.
Patriota P, Guessous I, Rezzi S, Marques-Vidal P
Nutrients. 2023; 15(18).
PMID: 37764829
PMC: 10534692.
DOI: 10.3390/nu15184046.
The Genetic Architecture of Vitamin D Deficiency among an Elderly Lebanese Middle Eastern Population: An Exome-Wide Association Study.
Hendi N, Chakhtoura M, Al-Sarraj Y, Basha D, Albagha O, Fuleihan G
Nutrients. 2023; 15(14).
PMID: 37513634
PMC: 10384558.
DOI: 10.3390/nu15143216.
The Role of Vitamin D for Human Health: The Challenge of the Right Study Designs and Interpretation.
Brenner H
Nutrients. 2023; 15(13).
PMID: 37447223
PMC: 10346222.
DOI: 10.3390/nu15132897.
About the associations of vitamin D deficiency and biomarkers of systemic inflammatory response with all-cause and cause-specific mortality in a general population sample of almost 400,000 UK Biobank participants.
Sha S, Gwenzi T, Chen L, Brenner H, Schottker B
Eur J Epidemiol. 2023; 38(9):957-971.
PMID: 37340242
PMC: 10501954.
DOI: 10.1007/s10654-023-01023-2.
